King® Guide to Parenteral Admixtures®
Loose-Leaf Edition

The Original Standard in Hospital Pharmacy Since 1971

Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.

King Guide loose-Leaf Edition

"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.

Features

  • Updated Quarterly Since 1971
  • Exceeds TJC Requirements
  • NABP Endorsed
  • Over 598 IV drugs with at-a-glance view of compatibility in 12 fluids
  • Over 3,200 Primary Source References
  • Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Y-Site, Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data.
  • Special Sections on Stability and Storage
  • Boxed Warning and Hazardous Drugs List and Identification
  • Proprietary and Generic Drug Names Included

Fall 2021

In this update we added new monographs for ANSUVIMAB-ZYKL, IBUPROFEN LYSINE, OLICERIDINE, and SETMELANOTIDE.

We also added new stability information to these existing drug monographs: IDARUBICIN HYDROCHLORIDE, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and TRASTUZUMAB.

New compatibility information was added to these existing drug monographs: ACETAMINOPHEN with 12 other drugs; CLONIDINE HYDROCHLORIDE, IBUPROFEN LYSINE with 20 other drugs; LEVOBUPIVACAINE; MEROPENEM; MORPHINE HYDROCHLORIDE; RIFAMPIN, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL; and TEDIZOLID PHOSPHATE.


Ready to Order?

Visit our Online Store

Buy Now